Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

[Predictive biomarkers of response to immune checkpoint inhibitors].

Frelau A, Pracht M, Le Sourd S, Lespagnol A, Corre R, Ménard C, Tarte K, Mosser J, Edeline J.

Bull Cancer. 2018 Mar 7. pii: S0007-4551(17)30384-3. doi: 10.1016/j.bulcan.2017.10.031. [Epub ahead of print] French.

PMID:
29525053
2.

Mapping child growth failure in Africa between 2000 and 2015.

Osgood-Zimmerman A, Millear AI, Stubbs RW, Shields C, Pickering BV, Earl L, Graetz N, Kinyoki DK, Ray SE, Bhatt S, Browne AJ, Burstein R, Cameron E, Casey DC, Deshpande A, Fullman N, Gething PW, Gibson HS, Henry NJ, Herrero M, Krause LK, Letourneau ID, Levine AJ, Liu PY, Longbottom J, Mayala BK, Mosser JF, Noor AM, Pigott DM, Piwoz EG, Rao P, Rawat R, Reiner RC, Smith DL, Weiss DJ, Wiens KE, Mokdad AH, Lim SS, Murray CJL, Kassebaum NJ, Hay SI.

Nature. 2018 Feb 28;555(7694):41-47. doi: 10.1038/nature25760.

3.

Mapping local variation in educational attainment across Africa.

Graetz N, Friedman J, Osgood-Zimmerman A, Burstein R, Biehl MH, Shields C, Mosser JF, Casey DC, Deshpande A, Earl L, Reiner RC, Ray SE, Fullman N, Levine AJ, Stubbs RW, Mayala BK, Longbottom J, Browne AJ, Bhatt S, Weiss DJ, Gething PW, Mokdad AH, Lim SS, Murray CJL, Gakidou E, Hay SI.

Nature. 2018 Feb 28;555(7694):48-53. doi: 10.1038/nature25761.

4.

Existing and potential infection risk zones of yellow fever worldwide: a modelling analysis.

Shearer FM, Longbottom J, Browne AJ, Pigott DM, Brady OJ, Kraemer MUG, Marinho F, Yactayo S, de Araújo VEM, da Nóbrega AA, Fullman N, Ray SE, Mosser JF, Stanaway JD, Lim SS, Reiner RC Jr, Moyes CL, Hay SI, Golding N.

Lancet Glob Health. 2018 Mar;6(3):e270-e278. doi: 10.1016/S2214-109X(18)30024-X. Epub 2018 Feb 2.

5.

A novel prognostic six-CpG signature in glioblastomas.

Yin AA, Lu N, Etcheverry A, Aubry M, Barnholtz-Sloan J, Zhang LH, Mosser J, Zhang W, Zhang X, Liu YH, He YL.

CNS Neurosci Ther. 2018 Mar;24(3):167-177. doi: 10.1111/cns.12786. Epub 2018 Jan 19.

PMID:
29350455
6.

Notes from the Field: Baylisascaris procyonis Encephalomyelitis in a Toddler - King County, Washington, 2017.

Kawakami V, Casto A, Natarajan N, Snyder A, Mosser J, Bonwitt J, Kronman MP, Kay M.

MMWR Morb Mortal Wkly Rep. 2018 Jan 19;67(2):79-80. doi: 10.15585/mmwr.mm6702a6. No abstract available.

7.

Dual IRE1 RNase functions dictate glioblastoma development.

Lhomond S, Avril T, Dejeans N, Voutetakis K, Doultsinos D, McMahon M, Pineau R, Obacz J, Papadodima O, Jouan F, Bourien H, Logotheti M, Jégou G, Pallares-Lupon N, Schmit K, Le Reste PJ, Etcheverry A, Mosser J, Barroso K, Vauléon E, Maurel M, Samali A, Patterson JB, Pluquet O, Hetz C, Quillien V, Chatziioannou A, Chevet E.

EMBO Mol Med. 2018 Mar;10(3). pii: e7929. doi: 10.15252/emmm.201707929.

8.

Integrative analysis of novel hypomethylation and gene expression signatures in glioblastomas.

Yin A, Etcheverry A, He Y, Aubry M, Barnholtz-Sloan J, Zhang L, Mao X, Chen W, Liu B, Zhang W, Mosser J, Zhang X.

Oncotarget. 2017 Jul 11;8(52):89607-89619. doi: 10.18632/oncotarget.19171. eCollection 2017 Oct 27.

9.

The triad of pruritus, xanthomas, and cholestasis: Two cases and a brief review of the literature.

Pearson HJ, Mosser JL, Jacks SK.

Pediatr Dermatol. 2017 Nov;34(6):e305-e308. doi: 10.1111/pde.13306. Review.

PMID:
29144045
10.

Mutational Landscape of DDR2 Gene in Lung Squamous Cell Carcinoma Using Next-generation Sequencing.

Ricordel C, Lespagnol A, Llamas-Gutierrez F, de Tayrac M, Kerjouan M, Fievet A, Hamdi-Rozé H, Aliouat A, Desrues B, Mosser J, Léna H.

Clin Lung Cancer. 2018 Mar;19(2):163-169.e4. doi: 10.1016/j.cllc.2017.10.006. Epub 2017 Oct 19.

11.

Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program.

Leduc C, Merlio JP, Besse B, Blons H, Debieuvre D, Bringuier PP, Monnet I, Rouquette I, Fraboulet-Moreau S, Lemoine A, Pouessel D, Mosser J, Vaylet F, Langlais A, Missy P, Morin F, Moro-Sibilot D, Cadranel J, Barlesi F, Beau-Faller M; French Cooperative Thoracic Intergroup (IFCT).

Ann Oncol. 2017 Nov 1;28(11):2715-2724. doi: 10.1093/annonc/mdx404.

PMID:
28945865
12.

CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma.

Avril T, Etcheverry A, Pineau R, Obacz J, Jegou G, Jouan F, Le Reste PJ, Hatami M, Colen RR, Carlson BL, Decker PA, Sarkaria JN, Vauléon E, Chiforeanu DC, Clavreul A, Mosser J, Chevet E, Quillien V.

Clin Cancer Res. 2017 Dec 1;23(23):7360-7374. doi: 10.1158/1078-0432.CCR-17-1549. Epub 2017 Sep 22.

13.

Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis.

Shearer FM, Moyes CL, Pigott DM, Brady OJ, Marinho F, Deshpande A, Longbottom J, Browne AJ, Kraemer MUG, O'Reilly KM, Hombach J, Yactayo S, de Araújo VEM, da Nóbrega AA, Mosser JF, Stanaway JD, Lim SS, Hay SI, Golding N, Reiner RC Jr.

Lancet Infect Dis. 2017 Nov;17(11):1209-1217. doi: 10.1016/S1473-3099(17)30419-X. Epub 2017 Aug 16.

14.

EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice.

Tomasini P, Brosseau S, Mazières J, Merlio JP, Beau-Faller M, Mosser J, Wislez M, Ouafik L, Besse B, Rouquette I, Debieuvre D, Escande F, Westeel V, Audigier-Valette C, Missy P, Langlais A, Morin F, Moro-Sibilot D, Zalcman G, Barlesi F.

Eur Respir J. 2017 Aug 10;50(2). pii: 1700514. doi: 10.1183/13993003.00514-2017. Print 2017 Aug.

PMID:
28798090
15.

Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatment.

Kammerer-Jacquet SF, Brunot A, Bensalah K, Campillo-Gimenez B, Lefort M, Bayat S, Ravaud A, Dupuis F, Yacoub M, Verhoest G, Peyronnet B, Mathieu R, Lespagnol A, Mosser J, Edeline J, Laguerre B, Bernhard JC, Rioux-Leclercq N.

Urol Oncol. 2017 Oct;35(10):603.e7-603.e14. doi: 10.1016/j.urolonc.2017.05.015. Epub 2017 Jun 12.

16.

Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line Therapy.

Kammerer-Jacquet SF, Medane S, Bensalah K, Bernhard JC, Yacoub M, Dupuis F, Ravaud A, Verhoest G, Mathieu R, Peyronnet B, Brunot A, Laguerre B, Lespagnol A, Mosser J, Dugay F, Belaud-Rotureau MA, Rioux-Leclercq N.

Target Oncol. 2017 Aug;12(4):487-494. doi: 10.1007/s11523-017-0498-1.

PMID:
28550387
17.

Characteristics and Outcomes of Patients with Lung Cancer Harboring Multiple Molecular Alterations: Results from the IFCT Study Biomarkers France.

Guibert N, Barlesi F, Descourt R, Léna H, Besse B, Beau-Faller M, Mosser J, Pichon E, Merlio JP, Ouafik L, Guichard F, Mastroianni B, Moreau L, Wdowik A, Sabourin JC, Lemoine A, Missy P, Langlais A, Moro-Sibilot D, Mazières J.

J Thorac Oncol. 2017 Jun;12(6):963-973. doi: 10.1016/j.jtho.2017.02.001. Epub 2017 Feb 9.

18.

Correction: From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity.

Aubry M, de Tayrac M, Etcheverry A, Clavreul A, Saikali S, Menei P, Mosser J.

Oncotarget. 2016 Oct 11;7(41):67685. doi: 10.18632/oncotarget.12550. No abstract available.

19.

A Retrospective Analysis Comparing the New Standardized Letter of Recommendation in Dermatology with the Classic Narrative Letter of Recommendation.

Kaffenberger JA, Mosser J, Lee G, Pootrakul L, Harfmann K, Fabbro S, Faith EF, Carr D, Plotner A, Zirwas M, Kaffenberger BH.

J Clin Aesthet Dermatol. 2016 Sep;9(9):36-42. Epub 2016 Sep 1.

20.

Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential.

Kammerer-Jacquet SF, Crouzet L, Brunot A, Dagher J, Pladys A, Edeline J, Laguerre B, Peyronnet B, Mathieu R, Verhoest G, Patard JJ, Lespagnol A, Mosser J, Denis M, Messai Y, Gad-Lapiteau S, Chouaib S, Belaud-Rotureau MA, Bensalah K, Rioux-Leclercq N.

Int J Cancer. 2017 Jan 1;140(1):142-148. doi: 10.1002/ijc.30429. Epub 2016 Sep 23.

21.

Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype.

Kammerer-Jacquet SF, Brunot A, Pladys A, Bouzille G, Dagher J, Medane S, Peyronnet B, Mathieu R, Verhoest G, Bensalah K, Edeline J, Laguerre B, Lespagnol A, Mosser J, Dugay F, Belaud-Rotureau MA, Rioux-Leclercq N.

Clin Genitourin Cancer. 2017 Feb;15(1):e1-e7. doi: 10.1016/j.clgc.2016.06.007. Epub 2016 Jun 27.

PMID:
27444986
22.

Wild-type VHL Clear Cell Renal Cell Carcinomas Are a Distinct Clinical and Histologic Entity: A 10-Year Follow-up.

Dagher J, Kammerer-Jacquet SF, Brunot A, Pladys A, Patard JJ, Bensalah K, Perrin C, Verhoest G, Mosser J, Lespagnol A, Vigneau C, Dugay F, Belaud-Rotureau MA, Rioux-Leclercq N.

Eur Urol Focus. 2016 Feb;1(3):284-290. doi: 10.1016/j.euf.2015.06.001. Epub 2015 Jun 17.

PMID:
28723401
23.

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT).

Barlesi F, Mazieres J, Merlio JP, Debieuvre D, Mosser J, Lena H, Ouafik L, Besse B, Rouquette I, Westeel V, Escande F, Monnet I, Lemoine A, Veillon R, Blons H, Audigier-Valette C, Bringuier PP, Lamy R, Beau-Faller M, Pujol JL, Sabourin JC, Penault-Llorca F, Denis MG, Lantuejoul S, Morin F, Tran Q, Missy P, Langlais A, Milleron B, Cadranel J, Soria JC, Zalcman G; Biomarkers France contributors.

Lancet. 2016 Apr 2;387(10026):1415-1426. doi: 10.1016/S0140-6736(16)00004-0. Epub 2016 Jan 15.

24.

From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity.

Aubry M, de Tayrac M, Etcheverry A, Clavreul A, Saikali S, Menei P, Mosser J.

Oncotarget. 2015 May 20;6(14):12094-109. Erratum in: Oncotarget. 2016 Oct 11;7(41):67685.

25.

GNPAT variant associated with severe iron overload in HFE hemochromatosis.

Bardou-Jacquet E, de Tayrac M, Mosser J, Deugnier Y.

Hepatology. 2015 Dec;62(6):1917-8. doi: 10.1002/hep.27854. Epub 2015 May 23. No abstract available.

PMID:
25891252
26.

Prognostic and predictive values of oncogenic BRAF, NRAS, c-KIT and MITF in cutaneous and mucous melanoma.

Pracht M, Mogha A, Lespagnol A, Fautrel A, Mouchet N, Le Gall F, Paumier V, Lefeuvre-Plesse C, Rioux-Leclerc N, Mosser J, Oger E, Adamski H, Galibert MD, Lesimple T.

J Eur Acad Dermatol Venereol. 2015 Aug;29(8):1530-8. doi: 10.1111/jdv.12910. Epub 2015 Jan 26.

PMID:
25623140
27.

Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis.

Lemée JM, Clavreul A, Aubry M, Com E, de Tayrac M, Eliat PA, Henry C, Rousseau A, Mosser J, Menei P.

J Neurooncol. 2015 Mar;122(1):53-61. doi: 10.1007/s11060-014-1695-8. Epub 2015 Jan 6.

28.

Identification of two glioblastoma-associated stromal cell subtypes with different carcinogenic properties in histologically normal surgical margins.

Clavreul A, Etcheverry A, Tétaud C, Rousseau A, Avril T, Henry C, Mosser J, Menei P.

J Neurooncol. 2015 Mar;122(1):1-10. doi: 10.1007/s11060-014-1683-z. Epub 2014 Dec 13.

29.

Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis.

de Tayrac M, Roth MP, Jouanolle AM, Coppin H, le Gac G, Piperno A, Férec C, Pelucchi S, Scotet V, Bardou-Jacquet E, Ropert M, Bouvet R, Génin E, Mosser J, Deugnier Y.

J Hepatol. 2015 Mar;62(3):664-72. doi: 10.1016/j.jhep.2014.10.017. Epub 2014 Oct 18.

30.

EFGR-mutant lung adenocarcinoma and Li-Fraumeni syndrome: report of two cases and review of the literature.

Ricordel C, Labalette-Tiercin M, Lespagnol A, Kerjouan M, Dugast C, Mosser J, Desrues B, Léna H.

Lung Cancer. 2015 Jan;87(1):80-4. doi: 10.1016/j.lungcan.2014.11.005. Epub 2014 Nov 20. Review.

31.

DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomide.

Etcheverry A, Aubry M, Idbaih A, Vauleon E, Marie Y, Menei P, Boniface R, Figarella-Branger D, Karayan-Tapon L, Quillien V, Sanson M, de Tayrac M, Delattre JY, Mosser J.

PLoS One. 2014 Sep 18;9(9):e104455. doi: 10.1371/journal.pone.0104455. eCollection 2014.

32.

A case of a generalized lichenoid tattoo reaction.

Jacks SK, Zirwas MJ, Mosser JL.

J Clin Aesthet Dermatol. 2014 Aug;7(8):48-50.

33.

Proteomic analysis underlines the usefulness of both primary adherent and stem-like cell lines for studying proteins involved in human glioblastoma.

Collet B, Avril T, Aubry M, Hamlat A, Le Reste PJ, Chiforeanu D, Vauleon E, Mosser J, Quillien V.

J Proteomics. 2014 Oct 14;110:7-19. doi: 10.1016/j.jprot.2014.07.022. Epub 2014 Aug 1.

PMID:
25088051
34.

Nasopharyngeal carriage and transmission of Streptococcus pneumoniae in American Indian households after a decade of pneumococcal conjugate vaccine use.

Mosser JF, Grant LR, Millar EV, Weatherholtz RC, Jackson DM, Beall B, Craig MJ, Reid R, Santosham M, O'Brien KL.

PLoS One. 2014 Jan 17;9(1):e79578. doi: 10.1371/journal.pone.0079578. eCollection 2014. Erratum in: PLoS One. 2014;9(3):e93878.

35.

Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients.

Quillien V, Lavenu A, Sanson M, Legrain M, Dubus P, Karayan-Tapon L, Mosser J, Ichimura K, Figarella-Branger D.

J Neurooncol. 2014 Feb;116(3):487-96. doi: 10.1007/s11060-013-1332-y. Epub 2014 Jan 14.

36.

A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platforms.

Beau-Faller M, Blons H, Domerg C, Gajda D, Richard N, Escande F, Solassol J, Denis MG, Cayre A, Nanni-Metellus I, Olschwang S, Lizard S, Piard F, Pretet JL, de Fraipont F, Bièche I, de Cremoux P, Rouquette I, Bringuier PP, Mosser J, Legrain M, Voegeli AC, Saulnier P, Morin F, Pignon JP, Zalcman G, Cadranel J.

J Mol Diagn. 2014 Jan;16(1):45-55. doi: 10.1016/j.jmoldx.2013.07.009. Epub 2013 Oct 30.

PMID:
24183959
37.

Prognostic significance of EDN/RB, HJURP, p60/CAF-1 and PDLI4, four new markers in high-grade gliomas.

de Tayrac M, Saikali S, Aubry M, Bellaud P, Boniface R, Quillien V, Mosser J.

PLoS One. 2013 Sep 11;8(9):e73332. doi: 10.1371/journal.pone.0073332. eCollection 2013.

38.

Mortality and long-term virologic outcomes in children and infants treated with lopinavir/ritonavir.

Estripeaut D, Mosser J, Doherty M, Acosta W, Shah H, Castaño E, Luciani K, Pascale JM, Bollinger RC, Page KR.

Pediatr Infect Dis J. 2013 Dec;32(12):e466-72. doi: 10.1097/INF.0b013e3182a09276.

39.

Immune genes are associated with human glioblastoma pathology and patient survival.

Vauléon E, Tony A, Hamlat A, Etcheverry A, Chiforeanu DC, Menei P, Mosser J, Quillien V, Aubry M.

BMC Med Genomics. 2012 Sep 14;5:41. doi: 10.1186/1755-8794-5-41.

40.

U.S. EPA response to the Fukushima Daiichi Nuclear Power Plant accident.

Tupin EA, Boyd MA, Mosser JE, Wieder JS.

Health Phys. 2012 May;102(5):563-9. doi: 10.1097/HP.0b013e31824cc02e.

PMID:
22469933
41.

Iron excess limits HHIPL-2 gene expression and decreases osteoblastic activity in human MG-63 cells.

Doyard M, Fatih N, Monnier A, Island ML, Aubry M, Leroyer P, Bouvet R, Chalès G, Mosser J, Loréal O, Guggenbuhl P.

Osteoporos Int. 2012 Oct;23(10):2435-45. doi: 10.1007/s00198-011-1871-z. Epub 2012 Jan 12.

PMID:
22237814
42.

Isolation of a new cell population in the glioblastoma microenvironment.

Clavreul A, Etcheverry A, Chassevent A, Quillien V, Avril T, Jourdan ML, Michalak S, François P, Carré JL, Mosser J; Grand Ouest Glioma Project Network, Menei P.

J Neurooncol. 2012 Feb;106(3):493-504. doi: 10.1007/s11060-011-0701-7. Epub 2011 Sep 18.

PMID:
21928115
43.

Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells.

Avril T, Vauleon E, Hamlat A, Saikali S, Etcheverry A, Delmas C, Diabira S, Mosser J, Quillien V.

Brain Pathol. 2012 Mar;22(2):159-74. doi: 10.1111/j.1750-3639.2011.00515.x. Epub 2011 Sep 16.

PMID:
21790828
44.

5q12.1 deletion: delineation of a phenotype including mental retardation and ocular defects.

Jaillard S, Andrieux J, Plessis G, Krepischi AC, Lucas J, David V, Le Brun M, Bertola DR, David A, Belaud-Rotureau MA, Mosser J, Lazaro L, Treguier C, Rosenberg C, Odent S, Dubourg C.

Am J Med Genet A. 2011 Apr;155A(4):725-31. doi: 10.1002/ajmg.a.33758. Epub 2011 Mar 15.

PMID:
21594994
45.

Mechanisms of immunomodulation in human glioblastoma.

Avril T, Vauleon E, Tanguy-Royer S, Mosser J, Quillien V.

Immunotherapy. 2011 Apr;3(4 Suppl):42-4. doi: 10.2217/imt.11.39. Review.

PMID:
21524170
46.

Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach.

Collet B, Guitton N, Saïkali S, Avril T, Pineau C, Hamlat A, Mosser J, Quillien V.

Proteome Sci. 2011 Apr 6;9(1):16. doi: 10.1186/1477-5956-9-16.

47.

[MGMT analysis in gliomas].

Quillien V, Vauléon E, Saikali S, Lesimple T, Hamlat A, Etcheverry A, Mosser J.

Bull Cancer. 2011 Mar;98(3):291-303. doi: 10.1684/bdc.2011.1332. Review. French.

48.

A 4-gene signature associated with clinical outcome in high-grade gliomas.

de Tayrac M, Aubry M, Saïkali S, Etcheverry A, Surbled C, Guénot F, Galibert MD, Hamlat A, Lesimple T, Quillien V, Menei P, Mosser J.

Clin Cancer Res. 2011 Jan 15;17(2):317-27. doi: 10.1158/1078-0432.CCR-10-1126. Epub 2011 Jan 11.

49.

DNA methylation in glioblastoma: impact on gene expression and clinical outcome.

Etcheverry A, Aubry M, de Tayrac M, Vauleon E, Boniface R, Guenot F, Saikali S, Hamlat A, Riffaud L, Menei P, Quillien V, Mosser J.

BMC Genomics. 2010 Dec 14;11:701. doi: 10.1186/1471-2164-11-701.

50.

Clinical and molecular characterization of 17q21.31 microdeletion syndrome in 14 French patients with mental retardation.

Dubourg C, Sanlaville D, Doco-Fenzy M, Le Caignec C, Missirian C, Jaillard S, Schluth-Bolard C, Landais E, Boute O, Philip N, Toutain A, David A, Edery P, Moncla A, Martin-Coignard D, Vincent-Delorme C, Mortemousque I, Duban-Bedu B, Drunat S, Beri M, Mosser J, Odent S, David V, Andrieux J.

Eur J Med Genet. 2011 Mar-Apr;54(2):144-51. doi: 10.1016/j.ejmg.2010.11.003. Epub 2010 Nov 20.

Supplemental Content

Loading ...
Support Center